CCR2 and myeloid sarcoma: ,22,23,24 We compared proportions of cells positive for CCR2, CCR5, CCR6, CXCR5, granzyme K, and CD25 between non-MS WM and MS normal-appearing and lesional WM CD8+ and CD4+ CD69+ T cells (Figures 6B and S4).